|
FY2025
12 months to Nov 29, 2025
|
FY2024
12 months to Nov 30, 2024
|
FY2023
12 months to Dec 2, 2023
|
FY2022
12 months to Dec 3, 2022
|
FY2021
12 months to Nov 27, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income including non-controlling interest | |||||
| Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization | |||||
| Deferred income taxes | |||||
| (Income) loss from equity method investments, net of dividends received | |||||
| (Gain) loss on disposal of assets | |||||
| Share-based compensation | |||||
| Loss on the sale of a business | |||||
| Loss on impairment of intangible asset | |||||
| Pension and other postretirement benefit plan contributions | |||||
| Pension and other postretirement benefit plan benefit | |||||
| Loss on impairment of assets held for sale | |||||
| Loss on impairment of equity investment | |||||
| Gain from insurance proceeds | |||||
| Debt issuance cost write-off | |||||
| (Gain) loss on fair value adjustment on contingent consideration liabilities | |||||
| Change in assets and liabilities, net of effects of acquisitions: | |||||
| Trade receivables, net | |||||
| Inventories | |||||
| Other assets | |||||
| Trade payables | |||||
| Accrued compensation | |||||
| Other accrued expenses | |||||
| Income taxes payable | |||||
| Other liabilities | |||||
| Foreign currency remeasurement | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchased property, plant and equipment | |||||
| Purchased businesses, net of cash acquired | |||||
| Proceeds from the sale of a business | |||||
| Purchase of cost method investment | |||||
| Purchase of non-controlling interest | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Proceeds from insurance recoveries | |||||
| Cash received from government grant | |||||
| Cash outflow related to government grant | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of long-term debt | |||||
| Repayment of long-term debt | |||||
| Payment of debt issue costs | |||||
| Net payment on notes payable | |||||
| Dividends paid | |||||
| Proceeds from stock options exercised | |||||
| Repurchases of common stock | |||||
| Contingent consideration payment | |||||
| Net cash (used in) provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Supplemental disclosure of cash flow information: | |||||
| Dividends paid with company stock | |||||
| Cash paid for interest, net of amount capitalized of $562, $1,859, and $1,769 for the years ended November 29, 2025, November 30, 2024 and December 2, 2023, respectively | |||||
| Cash paid for income taxes, net of refunds | |||||
Loading...